Schedule 13D ownership disclosure

CYTOMED THERAPEUTICS LIMITED

Ordinary Shares · CUSIP: Y1R80M106

Event date: 2025-02-20

Filing-level shares
2,673,325.00
Percent of class
23.17%
  • Choo Chee KongReported CIK 0001970632

    Shares: 2,673,325.00 · Class: 23.17%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-25-010435
Form type
SCHEDULE 13D/A
Filer
Choo Chee Kong
CIK
CIK 1970632
Filed
Mar 14, 2025
Reporting period
Feb 20, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub